Order Article Reprints

Niogret J, Limagne E, Thibaudin M, Blanc J, Bertaut A, Le Malicot K, Rinaldi Y, Caroli-Bosc F-X, Audemar F, Nguyen S, et al. Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. Cancers. 2020; 12(6):1429. https://doi.org/10.3390/cancers12061429

Niogret, Julie, Emeric Limagne, Marion Thibaudin, Julie Blanc, Aurelie Bertaut, Karine Le Malicot, Yves Rinaldi, François-Xavier Caroli-Bosc, Franck Audemar, Suzanne Nguyen, and et al. 2020. "Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma" Cancers 12, no. 6: 1429. https://doi.org/10.3390/cancers12061429

Niogret, J., Limagne, E., Thibaudin, M., Blanc, J., Bertaut, A., Le Malicot, K., Rinaldi, Y., Caroli-Bosc, F.-X., Audemar, F., Nguyen, S., Sarda, C., Lombard-Bohas, C., Locher, C., Carreiro, M., Legoux, J.-L., Etienne, P.-L., Baconnier, M., Porneuf, M., Aparicio, T., & Ghiringhelli, F. (2020). Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. Cancers, 12(6), 1429. https://doi.org/10.3390/cancers12061429